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SUMMARY
We assessed the ability oftwo screening protocols to detect varying degrees ofhyperglycaemia
in pregnancy and to comparefetal outcome in thosefound to have normal and abnormal glucose
metabolism by either protocol.
493 pregnant women were identified by one of two screening protocols to be at risk of
hyperglycaemia in pregnancy.
Pregnancy complications, induction of labour, method of delivery, birth weight, incidence of
congenital anomalies and neonatal complications were assessed; there were no significant
differences between those with normal and abnormal glucose metabolism detected by either
protocolapartfromasignificantlineartrendfortheincidenceoflargeforgestationalinfantswith
increasing hyperglycaemia in both groups.
Protocol B was as effective in detecting new hyperglycaemia in pregnancy as Protocol A. It
involved the use of a breakfast meal profile in the initial assessment ofthose screened positive,
reducing the need for glucose tolerance tests in the vast majority of cases. In the population
studied, hyperglycaemia in pregnancy was not associated with adverse fetal outcome.
INTRODUCTION
Hyperglycaemia in pregnancy is a term which
can be used to encompass a large spectrum of
disordered carbohydrate metabolism, which
ranges from the upper end of normality to overt
clinicaldiabetes. Pregnancyhasimportanteffects
on carbohydrate metabolism, exerted mainly
through a decrease in insulin sensitivity, which
results in higher post prandial blood glucose
levels. In pregnant women with a normal
pancreatic B cell reserve, insulin secretion is
increasedinresponsetothisdecreasedsensitivity,
and glucose homeostasis is restored.' Pregnancy
can thus unmask a defect in carbohydrate
metabolism in those who have a limited B cell
reserve, resulting in hyperglycaemia of varying
severity. Even in present day obstetric practice,
hyperglycaemia in pregnancy presents a major
risktothefetus, the effects ofwhichextendfrom
fetal life through neonatal life into adolescence.
Hyperglycaemia inpregnancy may damage fetal
pancreatic B cells, increasing susceptibility to
carbohydrate intolerance in the future.2'3
The aim of screening mothers for evidence of
abnormalcarbohydratemetabolisminpregnancy
is to minimise or eliminate these risks to the
fetus. There are a number of screening tests in
currentuse, withnoconsensus view astothebest
method. In the UK the methods more commonly
used include clinical risk factors, glycosuria,
random plasma glucose and glycosylated
haemoglobin. Each ofthese methods when used
alonehasrelativelylowsensitivityandspecificity.
Theaimofthis studywas tolookatfetaloutcome
in pregnancies complicated by varying degrees
of hyperglycaemia detected by two screening
protocolsbetween 1992and 1996.Thosemothers
identified by the two screening protocols to have
hyperglycaemia in pregnancy, went on to have
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either a 75 g oral glucose tolerance test (OGTT).
(1992-1994) or a 300 kcal breakfast meal test
(1994-1996). Fetal outcome in those found to
have normal and abnormal carbohydrate
metabolism by either test, was analysed, in an
attempttoascertainifeithertestwas a 'predictor'
for adverse fetal outcome.
PATIENTS AND METHODS
1. Protocol A
Between 1/3/92and28/2/94allpatientsattending
the ante-natal clinic in the Royal Maternity
Hospital (RMH) were screened at first booking
using 'clinical risk factors' and random venous
plasmaglucoseatbooking. Inadditionallpatients
had urine tested for glucose at each visit. (Table
I). Those mothers with one or more clinical risk
factors and/or random venous plasma glucose >
6.6mmol/1 and/orthepresence ofglycosuria> +
on two or more occasions; had a 75 g OGTT at
around28 weeks (75 gglucoseload, takenorally,
after an overnight fast, with venous plasma
glucose measured at 0, 30, 60, 90 and 120
minutes). Results were interpreted as shown in
Table II.
Those patients found to have impaired glucose
tolerance using these criteria went on to have a
meal profile. This consisted of 'breakfast' and
Table II
WHO criteriafor interpretation ofGTT
(adapted for pregnancy by "Diabetic pregnancy study
group" of the European association for the study of
diabetes (1989).
Venous plasma Normal Impaired D.M.
glucose G.T.
(mmol/l)
Fasting <6.0 6.0-7.9 .8
2 hour <9.0 9.0-10.9 .11.0
'lunch' meals,containing42gcarbohydrate (300
kcal) and 32 g carbohydrate (320 kcal)
respectively, with plasma glucose estimated
before and two 2 hours after each meal. Results
were interpreted as shown in Table III. The meal
profile was done in order to assess maternal
glycaemic response to normal diet and so
determineiftreatmentwas necessary. Ifamother
had an abnormal meal profile result she was
given dietary advice - restricted food intake to
1500-2000kcallday, andthemealprofilerepeated
in one week. Onlythen, ifonthe diettheresultof
the meal profile remained abnormal, was insulin
treatment considered. If a reading of 11 mmol/l
TABLE I
PROTOCOL A PROTOCOL B
Screening methods: Screening methods:
Clinical risk factors Random venous plasma glucose
(FH diabetes 1st degree relative, (RVPG) - Booking visit
previous baby>4.5 kg, previous - 28 weeks
unexplained stillbirth or neonatal Urine testing for glycosuria
death, previous fetal abnormality,
maternal weight >90 kg.) If RVPG >6.6 mmol/l
and/or glycosuria > + on two or Random venous plasma glucose mr cain-
(RVGP) - booking visit
mr cain--
Urine testing for glycosuria Breakfast meal test (as soon as possible)
(30% done because of IRVPG at booking)
Diagnosis Diagnosis
75 g oral glucose tolerance test (=28 wks) 75 g oral glucose tolerance test
(If clinical criteria and/or (If Breakfast meal test abnormal)
RVPG >6.6 mmol/l and/or
glycosuria > + on two or more occasions
(357 patients screened: 357 had a GTT) (136 patients screened: 3 had a GTT)
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or more was found at any time the patient was
diagnosed diabetic and insulin treatment
commenced.
Inthistwoyearperiod378motherswereidentified
by the screening protocol to be at risk of
hyperglycaemia in pregnancy and had a 75 g
OGTTperformed; 21 wereexcludedfromfurther
study for various reasons, including multiple
pregnancyandvomitingaftertheglucoseload. In
total, 357 singleton pregnancies were studied
(5.8% of the antenatal population).
TABLE III
Interpretation ofBreakfast Meal Test
2 hour glucose: mean = 5.2 mmol/l
mean + 2 S.D. = 6.8 mmol/l
Arbitrary cut-of 8 mmol/l
considered abnormal
(Roberts - study of 102 unselected mothers
whom had breakfast meal test - 1992 Belfast)
2. PROTOCOL B
Between 1/3/94 and 28/2/96 the screening
protocol was changed, so that mothers were not
identified to be atrisk ofhaving hyperglycaemia
inpregnancypurelybecauseofclinicalriskfactors
(Table I). Inaddition, adecision was takentotest
maternal glycaemic response to the intake of
normal foodstuffs, only proceeding to formal
glucosetolerancetesting ifthis was deemedtobe
abnormal.Duringthistwoyearperiod, allpatients
attending the antenatal clinic in RMH were
screenedusingrandomvenousplasmaglucose at
booking at 28 weeks and at any other time if
thoughtnecessarybytheobstetrician. Allpatients
had urine tested for glucose at each antenatal
visit.Thosepatientswitharandomvenousplasma
glucose>6.6mmol/1 orthepresenceofglycosuria
on two or more occasions went on to have a
breakfast meal test.
The breakfast meal test consisted of a 300 kcal
breakfast meal, containing 40 g ofcarbohydrate
- a standard portion of breakfast cereal, two
rounds of toast, milk, butter and a cup of tea. It
was undertaken after an overnight fast, venous
plasma glucose being estimated before and two
hours after the meal. Results were interpreted as
showninTableIII. Forthepurposeofcomparison
with the group ofpatients found to have IGT by
the 75 g OGTT in 1992-94, those patients who
had a 2 hr glucose < 8 mmol/1 were subdivided
into two groups (1) two hr glucose < 6.8 mmol/1
and (2) two hr glucose 6.9-7.9 mmol/l. Those
patients withabnormalresults weregivendietary
advice (foodintake restricted to 1500-2000 kcal/
day), and the breakfast meal test repeated in one
week. Ifafter one week on the diet the breakfast
meal test result was still abnormal, as defined
above, a 75 g OGTT was performed. A blood
glucoseof> 11 mmol/1 wasregardedasdiagnostic
ofdiabetes, and insulin treatment considered. In
total, 155 mothershadabreakfastmealtestinthis
twoyearperiod, ofwhom 19 wereexcludedfrom
further study because of the reasons outlined
previously. Therefore, 136 singletonpregnancies
identified by the screening protocol in this two
year period were studied (2.4% of the antenatal
population).
RESULTS
Of the 357 glucose tolerance tests undertaken,
243 (68%) werecarriedoutpurelybecauseofone
ormorepositiveclinicalcriteria,70(20%)because
of glycosuria, and 35 (10%) because of a raised
blood glucose (>6.6 mmol/1). Nine patients had
a GTT performed for other reasons, which
included 'large baby', 'polyhydramnios' and
'obstetrician request' and a number of patients
had more than one indication. Of these mothers
12werefoundtohaveimpairedglucosetolerance
(IGT) andthree tohavegestational diabetes. The
12 mothers with IGT had a meal profile, four of
whichwere abnormal. These mothers weregiven
dietaryadviceandnonerequiredinsulintreatment.
Of the three mothers found to have gestational
diabetes two were started on insulin and one was
treated with diet only.
Intotal, 136patients had abreakfastmealtest, of
which 106 (78%) were carried out because of a
random venous plasma glucose > 6.6 mmol/l, 18
(13%) because of glycosuria and 10 for reasons
other than these (mainly 'obstetrician request' -
because ofone ormorepositive clinicalcriteria).
Of these mothers three were found to have
abnormal results. They were all given dietary
advice initially. Two mothers had the breakfast
meal test repeated; in both cases it was still
abnormal and a 75 g OGTT was performed and a
diagnosis of diabetes mellitus made. The other
patient was admitted to hospital with acute
appendicitis before the test could be repeated,
andwasdiagnosedwithdiabetes whileinhospital.
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All three patients with abnormal breakfast meal
tests required insulin treatment.
Most patients had glycosylated haemoglobin
(HbA1I) measured at the time of the GTT or
breakfast meal test. The methods used for
estimating HbAlc changed twice in the four year
period and the results have been adapted
accordingly. HbA1c was significantly higher
(p <0.05) in those with IGT (3.8%) compared to
normal GTT results (3.2%) and in those with
abnormal (4.5%) compared to normal breakfast
test results (3.5%).
Pregnancy-inducedhypertension,pre-eclampsia,
urinarytractinfection, andpolyhydramnios were
thecommonestantenatalcomplications, butnone
wasfoundtobemorecommoninmotherswithan
abnormal GTT or breakfast meal test. Labour
was induced in 150 (44%) of those with normal
GTT results, 5 (42%) of those with IGT, and in
one gestational diabetic mother (33%). In those
who hadthe breakfast meal test, 52 (39%) with a
normalresult, andnoneofthosewithanabnormal
result, had labour induced.
Most mothers with normal GTT and breakfast
meal test results had normal vaginal deliveries.
Eight mothers with impaired glucose tolerance
had a caesarean section, four being elective
(previous caesarean sectioninthreepatients, and
primaryinfertilityina37yearold)andfourbeing
emergencycaesareansections.Ahigherincidence
of caesarean section associated with impaired
glucose tolerance has beenreportedbefore.6 The
caesarean section rates for those with normal
GTTandbreakfastmealtestresults are similarto
the Royal Maternity Hospital overall caesarean
section rates for that period (Table IV).
Fetal outcomes for the two groups are shown in
Table V. There was no increase in perinatal
mortality or incidence of birth trauma in babies
born to mothers with abnormal tests in either
group. There were no statistically significant
differences in birth weight or gestational age at
deliveryinbabiesborntomotherswithabnormal
tests in either group. There was a significant
linear trend (p <0.001) in the incidence of large
for gestational age babies with increasing
hyperglycaemiainbothgroups. Mostbabieswith
congenitalabnormalities, majorandminor,inthe
study group were born to mothers with normal
GTTorbreakfastmealtestresults. MeanAPGAR
scores at one and five minutes were similar in
those babies born to mothers with normal and
abnormal GTT and breakfast meal test results.
TABLE IV
Mode ofdelivery
Glucose Tolerance Test Breakfast Meal Test
Normal IGT DM Normal Normal AB-
(<6.8) (6.9-7.9) Normal
342 12 3 123 10 3
Normal 226 4 1 73 5 2
Delivery 66% 33% 33% 59% 50% 67%
Instrumental 48 0 1 15 1 0
Delivery 14% 33% 12% 10%
Caesarean 67 8 1 35 4 1
Section (total) 20% 67% 33% 28% 40% 33%
All IDDM All IDDM
Caesarean
Section Rate 21% 47% 24% 52%
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TABLE V
Fetal outcomesforpregnancies studied by Oral Glucose Tolerance test or Breakfast Meal Test
Glucose Tolerance Test Breakfast Meal Test
Normal IGT DM Normal Normal Abnormal
2 Hour Glucose (<9.0) (9.0-10.9) (>11) (<6.8) (6.8-7.9) (>8.0)
(mmol/l)
No. ofPatients 342 12 3 123 10 3
Mean Birth
Weight (kg) 3.54 3.79 3.26 3.46 4.04 3.25
Mean Gestational
Age (weeks 39.1 38.1 37.3 39.0 39.1 36.7
Large for
Gestational Age 72(21%) 6(50%) 1(33%) 22(17%) 4(40%) 2(67%)
Minor Congenital
Abnormality 44(13%) 1(8%) 1(33%) 7(6%) 1(10%) 0(0%)
Major Congenital
Abnormality 5(1%) 0(0%) 0(0%) 4(3%) 0(0%) 0(0%)
The incidence ofneonatal complications known
be more common in the infant of the diabetic
mother was assessed. There was no evidence to
suggest that any of these complications were
more common in those babies born to mothers
with hyperglycaemia in pregnancy. Most babies
who required admission to the special care baby
unit were born to mothers with normal GTT or
breakfast meal test results.
During the four year period studied, only six
cases of gestational diabetes were discovered;
three bythe GTT andthree by thebreakfast meal
test. Five of these patients were treated with
insulin, and all stopped insulin post-delivery.
They were all seen subsequently at the Royal
Victoria Hospital. Clinical records were traced
forfourofthefivepatients, allofwhomnowhave
Type 1 diabetes and are on insulin treatment.
DISCUSSION
The aim of screening mothers for evidence of
abnormalcarbohydratemetabolisminpregnancy
is to detect the problem at an early stage and so
prevent any adverse fetal outcome. The only
meaningful criteria by which to judge the
importance ofthe state ofglucose metabolism in
pregnancyarefetaloutcome,eitherintheshortor
longerterm, orthe long termmaternal outcome.6
Various indices offetal outcome have been used
to assess the effect of hyperglycaemia in
pregnancy. Because of the general decline in
perinatalmortalityratesinrecentyears,thisindex
of fetal outcome can no longer be used as a
practicaloutcomemeasure. Thereforeothershort
term pregnancy outcomes have become more
important in assessing the effect, if any, of
maternal hyperglycaemia.7 Maternal hyper-
glycaemia through its effect on fetal cells, can
cause accelerated fetal growth. The fetal B cells
are stimulated to produce insulin,2 an anabolic
hormone which causes visceral enlargement and
excessfatdeposition,7resultinginthemacrosomic
infant. Higherrates ofbirthtraumaandoperative
delivery are seen in these pregnancies,3, 8, 9
with resulting effects on maternal and neonatal
morbidity.2
Fetal hyperinsulinaemia may also inhibit the
pulmonary maturation processes necessary for
surfactant production,'0 and so contribute to the
increased incidence of respiratory distress
syndrome seen in infants of diabetic mothers.
The enhanced responsiveness of the fetal B cell
may extend into neonatal life and contribute to
the development of neonatal hypoglycaemia.'0
Other indices of neonatal morbidity have been
used as outcome measures. Maresh'1 found that
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hypoglycaemiaandpolycythaemia, oradmission
to a special care baby unit was significantly
related to the severity ofgestational diabetes but
not with maternal age or obesity. He also found
that birth weight was more related to maternal
obesitythantoageortoseverityofthegestational
diabetes.
There are relatively few studies offetal outcome
inmotherswithlesserdegreesofhyperglycaemia
in pregnancy. Talligaro12 found an association
with adverse fetal outcome - macrosomia,
congenitalabnormality, anddeliverybycaesarean
section in mothers with milder degrees of
hyperglycaemia in pregnancy. The Toronto tri-
hospital studyfoundagradedincrease inadverse
materno-fetal outcomes associated with
increasing carbohydrate intolerance in women
without gestational diabetes.8 Roberts6 did not
find any adverse fetal outcome or neonatal
morbidity, but he was able to demonstrate a
significantly higher caesarean section rate for
mothers with impaired glucose tolerance.
Thereiswellestablishedevidencethatgestational
diabetes increases the subsequent risk of
developing diabetes mellitus.2'31 3 The third
International Workshop Conference on
gestational diabetes2 recommended that these
women should be educated regarding symptoms
of overt diabetes, and be followed up at regular
intervals. There is evidence that the offspring of
women with gestational diabetes have an
increased risk of obesity in adolescence and of
developing glucose intolerance in the future.2
Identification and treatment of hyperglycaemia
in pregnancy may thus have far reaching
implications for the next generation.
Thereisnodoubtthatidentificationandtreatment
ofmothers withfrankdiabetes inpregnancy is of
benefit to mother and fetus. What is less certain
is the benefit of identifying lesser degrees of
hyperglycaemia, and screening for hyper-
glycaemia is the subject of much controversy.
Thereis no consensus aboutwhoto screen, when
to screen, which screening test to use, which
diagnostic test to use, and how to interpret the
results. The resulting effect is widespread
variation in practice between different units,
highlightedintworecentreports.Nelson-Piercy14
looked at practices in one Regional Health
Authority in London, and Jardine Brown15
analysed a nationwide survey on screening for
gestational diabetes. This latter report, compiled
by the Pregnancy and Neonatal Care group,
reveals that most units in the United Kingdom
useroutinetestingforglycosuriaandclinicalrisk
factors as the basis for screening, with only a
minorityusingroutinebloodglucosetesting. The
75 g OGTT is the most widely used diagnostic
test, being undertaken in many units solely
because ofpositive clinical risk factors.
The aim of screening for a condition is to detect
itatastagewheretreatmentwillimproveoutcome.
The screening test should be sensitive, specific,
acceptable, andthetreatmentmustbeeffective.16
Jarrett17 has arguedthat screening forgestational
diabetesdoesnotfulfilthecriteriaforascreening
test; it does not have an agreed definition, and
there is no consensus about management. He did
however acknowledge the value of screening in
predicting future risk of non insulin dependent
diabetes for the mother, but found few, if any,
benefits to the fetus. Carpenter 18suggested that
identificationofpregnantwomenwithpreviously
unknown defects in carbohydrate metabolism
'maybejustified as ascreening measure forlater
diabetes, since women so identified may benefit
fromlatermedicalfollow-up'.Healsoreferredto
fetal benefits of diagnosis and treatment of
hyperglycaemiainpregnancyintermsofreduced
perinatal mortality and morbidity.
There are a number of screening tests in current
use,withnoconsensusviewastothebestmethod.
Overall, the highest sensitivity and specificity
forthe outcomeofa 100 g GTT is found withthe
50 g oral glucose challenge test,19 recommended
by the American Diabetes Association.20 In the
UK, this method has not found favour,15 and the
methods used more commonly include:
(i) Clinical risk factors (potential diabetic
features) suchasglycosuria,previousinfant>4.5
kg, previous stillbirth, neonatal death or
congenitalabnormalityandmaternalobesity.The
use of these clinical risk factors alone has low
sensitivity and specificity, 50% and 66%
respectively in one review,2' and 50 and 50% in
another.19 Coustan suggested that the taking of a
history can be used as a screening test, and that
the sensitivity can be increased by combining it
with maternal age (>25 years) and obesity (pre-
pregnancy weight >150 pounds), but screening
by this method is thought to be relatively
inefficient. Gillmer22 in his review ofdiabetes in
pregnancy found that at least 30% of patients
withgestationaldiabetesdonothavesuchfeatures
in their history.
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(ii) Glycosuria: Sutherland 23 reported a
prevalence of glycosuria in pregnant women of
11.3%, and found that glycosuria in a second
fasting sample (not random glycosuria), was
associated with an increased risk of gestational
diabetes (15%). Pettitt3 showed that random
glycosuriainthethirdtrimesterwasmorecommon
with increasing hyperglycaemia. However, a
substantial number of women with hyper-
glycaemiainpregnancywillnothaveglycosuria,
and as ascreening methoditis oflow sensitivity.
(iii) Random blood sugar has been evaluated as
a method of screening by various investigators.
Jowett24 and Nasratt25 agreed that this method
used alone was not an efficient screening test.
O'Sullivan13 howeverfound thatarandomblood
glucose, when combined with maternal age >25
years as ascreeningtest, had asensitivity of88%
andspecificityof82%. Maresht2l inhisreviewof
glucoseintoleranceinpregnancyreportedhigher
sensitivities when random blood glucose was
combined with potential diabetic features as a
screening test.
(iv) Glycosylatedhaemoglobin(HbAi) HbA1cis
ausefulindicatorofbloodglucoselevelsoverthe
preceding 4-12 weeks. In diabetic pregnancy,
high levels of HbAic have been shown to be
associated with an increased risk of congenital
malformation26 and perinatal death.27 Although
HbAicisusedby someunits as ascreeningtestfor
hyperglycaemiainpregnancy15itsvaluehasbeen
questioned. It has been found to be of low
sensitivity and specificity in one study28 even
though meanHbAiclevels wereraisedinpatients
with carbohydrate intolerance diagnosed by a
3 hr 100 g OGTT. In another study HbAic was
found to have a poor predictive value for
pregnancy outcome. (Personal Communication) Lind
recommended that all units use random blood
glucose as a basis for screening, and the 75 g
OGTTfordiagnosis,interpretedbyWHOcriteria,
for the sake of international uniformity in the
diagnosis ofhyperglycaemia in pregnancy.29
There is no consensus view as to thebestmethod
ofscreeningforhyperglycaemiainpregnancy. In
the absenceofanagreed standard, JardineBrown
in the report of the pregnancy and neonatal care
group'5 has suggested a screening protocol. This
involves urine testing for glycosuria at every
antenatal visit, timed random glucose
measurements at booking, 28 weeks and ifthere
is > + glycosuria). The report recommends that a
75 g oral GTT is performed, followed by a meal
profile if the GTT is abnormal, before deciding
on treatment.
Gestationaldiabetes, asdefinedbytheWHO 30,31
is diagnosed using a 75 g oral glucose tolerance
test (OGTT) withbloodglucose estimations at0,
30, 60, 90 and 120 minutes, and defined cut-off
points fordiagnosis at0 and 120 minutes. It now
includes a category of "impaired gestational
glucose tolerance" (IGT), an intermediate
category between normality and gestational
diabetes. In North America the 100 g OGTT is
morecommonlyusedfordiagnosis ofgestational
diabetes, defined by the American Diabetes
Association, using cut-offpoints at 0, 1, 2 and 3
hours (NDDG criteria).2'7 A 50 g OGTT is used
by the Americans as a screening test to identify
those mothers requiring a 100 g OGTT, but is
used by some as the diagnostic test.'4
TheOGTThastraditionallybeenusedtodiagnose
gestational diabetes. It uses an unphysiological
glucose load I which may be unpalatable to
pregnant women.32 The results do not reflect the
levels of blood glucose to which the fetus is
normally exposed. It seems more logical,
therefore, to studymaternalglycaemic responses
to the intake of normal foodstuffs, since it is
hyperglycaemia in relation to normal diet that is
likely to be associated with adverse fetal
outcome.33 Indeed, many centres measure blood
glucose before and after a normal 'standardised
meal, in mothers with an abnormal GTT result,
before considering the need for treatment. We
felt that it would be more logical to identify
abnormal meal profile responses as the primary
diagnostic process.33 A number of studies have
looked at maternal glucose responses to more
physiological "meals". Sutherlandandcolleagues
in Aberdeen32 found that glucose response to a
standardised breakfast test meal correlated more
closely with percentile birth weight than the 75 g
OGTT. Cheneyandcolleagues34showeddifferent
insulin and glucose responses to a breakfast
tolerance test in lean and obese women with
gestational diabetes.
They concluded that a simple breakfast meal test
was useful in assessing pregnant women with
gestational diabetes, and that it was more
physiological than glucose loading. Roberts'
compared the 75 g OGTT and a simple 300 kcal
breakfastmealtestfortheirabilitytopredictfetal
outcome. HefoundthatintheBelfastpopulation,
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neither test was a useful indicator of pregnancy
outcome in mothers not already known to be
diabetic, and that there was no benefit in
continuing the test into the pre and post lunch
period. Whether or not the breakfast test will be
of any value in predicting the risk of future
diabetes in the mother remains to be seen.
In conclusion, the breakfast meal test is as
effective in detecting hyperglycaemia in
pregnancy as the traditional 75 g OGTT. It is a
morephysiological testofglucosemetabolismin
pregnancy and is likely to be more acceptable to
patients. Wedidnotfindanyevidenceofadverse
fetaloutcome associatedwithhyperglycaemiain
pregnancy, but did find that there was a high
incidence ofsubsequentType 1 diabetes inthose
mothers found to have gestational diabetes. The
forthcoming HAPO (Hyperglycaemia and
Adverse Pregnancy Outcome) study aims to
identify in a much largerpopulation, made up of
various ethnic groups in different countries,
whether lesser degrees of hyperglycaemia in
pregnancy are associated with increased risk of
adverse maternal, fetal or neonatal outcome.
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